Beyond its potential as a CM therapeutic target, DPEP1 was identified as a candidate for treating other nonmelanoma tumors (OR = 0.767, 95% CI: 0.693–0.849, FDR < 0.01), such as basal cell carcinoma. This evidence concerns the gene DPEP1 and basal cell carcinoma.